Cargando…

Body Composition Analysis of 10 Years versus 5 Years of Adjuvant Endocrine Therapy in Patients with Nonmetastatic Breast Cancer

OBJECTIVE: Our study aims to investigate the association of extended adjuvant endocrine therapy with disease-free survival (DFS), muscle mass, muscle strength, and visceral adipose tissue in patients with nonmetastatic breast cancer and the effect of extended endocrine therapy on body composition. P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Ruyi, Cheng, Xinran, Liu, Jun, Lai, Xu, Wang, Ruifeng, Yu, Dongchang, Fan, Yanan, Yu, Zhaoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826243/ https://www.ncbi.nlm.nih.gov/pubmed/33510788 http://dx.doi.org/10.1155/2021/6659680

Ejemplares similares

Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer
por: Li, Li, et al.
Publicado: (2018)

Completion of 5-year adjuvant endocrine therapy in the community
por: Makubate, B, et al.
Publicado: (2010)

PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy
por: Fan, Yu, et al.
Publicado: (2022)

Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
por: Shida, Yohei, et al.
Publicado: (2017)

Postoperative Adjuvant Sorafenib or Sunitinib for Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus: a Prospective Cohort Study
por: Gu, Liangyou, et al.
Publicado: (2017)

Computed tomography assessment of body composition in patients with nonmetastatic breast cancer: what are the best prognostic markers?
por: Oliveira Júnior, José Carlos, et al.
Publicado: (2022)

Factors associated with cognitive impairment during the first year of treatment for nonmetastatic breast cancer
por: Rodriguez, Nicole, et al.
Publicado: (2021)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Qian, Xinye
Publicado: (2023)

A 5‐year survival status prognosis of nonmetastatic cervical cancer patients through machine learning algorithms
por: Yu, Wenke, et al.
Publicado: (2022)

Extending Adjuvant Endocrine Therapy for 10 Years: A Mixed-Methods Analysis of Women’s Decision Making in an Online Breast Cancer Forum
por: Eraso, Yolanda, et al.
Publicado: (2021)

Dexa Body Composition Assessment in 10-11 Year Healthy Children
por: Verduin, W. M., et al.
Publicado: (2016)

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Famularo, Simone, et al.
Publicado: (2023)

The Christie hospital adjuvant tamoxifen trial--status at 10 years.
por: Ribeiro, G., et al.
Publicado: (1988)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

De‐escalation of five‐year adjuvant endocrine therapy in patients with estrogen receptor‐low positive (immunohistochemistry staining 1%‐10%) breast cancer: Propensity‐matched analysis from a prospectively maintained cohort
por: Cai, Yu‐Wen, et al.
Publicado: (2022)

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
por: Ribi, K, et al.
Publicado: (2012)

Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review
por: Yussof, Izzati, et al.
Publicado: (2022)

Etiology of precocious puberty, 10 years study in Endocrine Reserch Centre (Firouzgar), Tehran
por: Rohani, Farzaneh, et al.
Publicado: (2012)

Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer
por: Fadelu, Temidayo A., et al.
Publicado: (2022)

Body weight at 10 years of age and change in body composition between 8 and 10 years of age were related to survival in a longitudinal study of 39 Labrador retriever dogs
por: Penell, Johanna Christina, et al.
Publicado: (2019)

A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer
por: Guillaumier, Stephanie, et al.
Publicado: (2018)

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation
por: Aizawa, Rihito, et al.
Publicado: (2019)

Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer
por: Bhattacharyya, Tapesh, et al.
Publicado: (2018)

Accuracy and reliability of the InBody 270 multi-frequency body composition analyser in 10-12-year-old children
por: Larsen, Malte Nejst, et al.
Publicado: (2021)

Adjuvant radiotherapy in central hepatocellular carcinoma after narrow-margin hepatectomy: A 10-year real-world evidence
por: Rong, Weiqi, et al.
Publicado: (2020)

Minimally invasive surgery versus laparotomy of nonmetastatic pT4a colorectal cancer: a propensity score analysis
por: Guo, Hui-Long, et al.
Publicado: (2023)

Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer
por: Tian, Yu, et al.
Publicado: (2018)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

High Preoperative Plasma Fibrinogen Independently Predicts a Poor Prognosis in Patients with Nonmetastatic RCC
por: Wang, Zhan, et al.
Publicado: (2020)

Long-term oncologic outcomes of postoperative adjuvant versus salvage radiotherapy in prostate cancer: Systemic review and meta-analysis of 5-year and 10-year follow-up data
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Time‐dependent and nonlinear effects of prognostic factors in nonmetastatic colorectal cancer
por: Chi, Sheng‐Qiang, et al.
Publicado: (2017)

Associations between composite dietary antioxidant index and estimated 10-year atherosclerotic cardiovascular disease risk among U.S. adults
por: Zhang, Jia, et al.
Publicado: (2023)

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience
por: Brunello, Antonella, et al.
Publicado: (2015)

Adjuvant therapy for high‐risk cutaneous squamous cell carcinoma: 10‐year review
por: Newman, Jason G., et al.
Publicado: (2021)

Prognostic Value of Preoperative Fibrinogen for Predicting Clinical Outcome in Patients with Nonmetastatic Colorectal Cancer
por: Sun, Yu, et al.
Publicado: (2020)

Nonmetastatic Ewing's Sarcoma of the Lumbar Spine in an Adult Patient
por: Iacoangeli, Maurizio, et al.
Publicado: (2012)

Apalutamide for the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer
por: Patel, Urvi J., et al.
Publicado: (2019)

Treatment options of metastatic and nonmetastatic VIPoma: a review
por: Azizian, Azadeh, et al.
Publicado: (2022)

Effect of Radiotherapy Dose on Outcome in Nonmetastatic Ewing Sarcoma
por: Kersting, Josephine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e43u8etgh6jpsjb2emj508sgk1